Cargando…

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy

Expression of ATP-binding cassette (ABC) transporters has long been implicated in cancer chemotherapy resistance. Increased expression of the ABCC subfamily transporters has been reported in prostate cancer, especially in androgen-resistant cases. ABCC transporters are known to efflux drugs but, rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emmanouilidi, Aikaterini, Casari, Ilaria, Gokcen Akkaya, Begum, Maffucci, Tania, Furic, Luc, Guffanti, Federica, Broggini, Massimo, Chen, Xi, Maxuitenko, Yulia Y., Keeton, Adam B., Piazza, Gary A., Linton, Kenneth J., Falasca, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465469/ https://www.ncbi.nlm.nih.gov/pubmed/32718079 http://dx.doi.org/10.3390/cancers12082022

Ejemplares similares

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
por: Adamska, Aleksandra, et al.
Publicado: (2019)

Lysophosphatidylinositol Signalling and Metabolic Diseases
por: Arifin, Syamsul A., et al.
Publicado: (2016)

Targeting PDK1 for Chemosensitization of Cancer Cells
por: Emmanouilidi, Aikaterini, et al.
Publicado: (2017)

Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers
por: Mattox, Tyler E., et al.
Publicado: (2019)

Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth
por: Cisse, Ouma, et al.
Publicado: (2019)

Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer
por: Emmanouilidi, Aikaterini, et al.
Publicado: (2019)

Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts
por: Falasca, Marco, et al.
Publicado: (2014)

Inositol Polyphosphate-Based Compounds as Inhibitors of Phosphoinositide 3-Kinase-Dependent Signaling
por: Maffucci, Tania, et al.
Publicado: (2020)

Signalling Properties of Inositol Polyphosphates
por: Maffucci, Tania, et al.
Publicado: (2020)

Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning
por: Mosca, Maria Giovanna, et al.
Publicado: (2021)

Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts
por: Ricci, Francesca, et al.
Publicado: (2017)

Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion
por: Whitt, Jason D., et al.
Publicado: (2016)

GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells
por: Bondarenko, Alexander, et al.
Publicado: (2010)

MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis
por: Massey, William J., et al.
Publicado: (2023)

Diet and Pancreatic Cancer Prevention
por: Casari, Ilaria, et al.
Publicado: (2015)

The l-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
por: Moreno-Navarrete, José María, et al.
Publicado: (2012)

Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation
por: Xu, Keman, et al.
Publicado: (2021)

Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion
por: Mavrommati, Ioanna, et al.
Publicado: (2016)

The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis
por: Hofmann, Nicole A, et al.
Publicado: (2015)

Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
por: Andradas, Clara, et al.
Publicado: (2016)

Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS
por: Ward, Antonio B., et al.
Publicado: (2020)

Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
por: Chiappa, Michela, et al.
Publicado: (2022)

The GPR55 agonist lysophosphatidylinositol directly activates intermediate-conductance Ca(2+)-activated K(+) channels
por: Bondarenko, Alexander I., et al.
Publicado: (2011)

GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination
por: Wu, Chia-Shan, et al.
Publicado: (2013)

Dissecting lipid metabolism alterations in SARS-CoV-2
por: Casari, Ilaria, et al.
Publicado: (2021)

A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate
por: Falasca, M, et al.
Publicado: (2010)

Lysophosphatidylinositol Causes Neurite Retraction via GPR55, G(13) and RhoA in PC12 Cells
por: Obara, Yutaro, et al.
Publicado: (2011)

Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
por: Medina-Vera, Dina, et al.
Publicado: (2020)

The L‐α‐Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis
por: Fondevila, Marcos F., et al.
Publicado: (2020)

Lysophosphatidylinositol Induced Morphological Changes and Stress Fiber Formation through the GPR55-RhoA-ROCK Pathway
por: Nakajima, Keisuke, et al.
Publicado: (2022)

Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors
por: Martínez-Aguilar, Lizbeth Magnolia, et al.
Publicado: (2023)

Warm Ischemia Induces Spatiotemporal Changes in Lysophosphatidylinositol That Affect Post-Reperfusion Injury in Normal and Steatotic Rat Livers
por: Shibata, Kengo, et al.
Publicado: (2023)

Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression
por: Chikh, Anissa, et al.
Publicado: (2016)

Bixin and Fuxoxanthin Alone and in Combination with Cisplatin Regulate ABCC1 and ABCC2 Transcription in A549 Lung Cancer Cells
por: Chandra, Ferdy, et al.
Publicado: (2023)

A novel and selective PDK1 inhibitor reduces breast cancer cell invasion and tumour growth
por: Raimondi, C, et al.
Publicado: (2010)

Lysophosphatidylinositol-Acyltransferase-1 (LPIAT1) Is Required to Maintain Physiological Levels of PtdIns and PtdInsP(2) in the Mouse
por: Anderson, Karen E., et al.
Publicado: (2013)

l‐α‐Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK‐dependent pathway
por: Robertson‐Gray, Olivia J., et al.
Publicado: (2019)

Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration
por: Maffucci, Tania, et al.
Publicado: (2005)

A Phosphoinositide 3-Kinase/Phospholipase Cgamma1 Pathway Regulates Fibroblast Growth Factor-Induced Capillary Tube Formation
por: Maffucci, Tania, et al.
Publicado: (2009)

Roles of ABCC1 and ABCC4 in Proliferation and Migration of Breast Cancer Cell Lines
por: Low, Floren G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b8ic0gv4ciif7at1jh40dpu3t9